ATAI LIFE SCIENCES NV (9VC.DE) Stock Analyst Earnings Estimates
FRA:9VC - Deutsche Boerse Ag - NL0015000DX5 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.38M | 230K -98.87% | 314K 36.52% | 565.417K 80.07% | 255K -54.90% | 306K 20.00% | 78.243M 25,469.61% | 346.95M 343.43% | 663.09M 91.12% | 1.193B 79.92% | 1.166B -2.26% | 1.817B 55.83% | |
| EBITDA YoY % growth | -120.28M -30.55% | -144.26M -19.94% | -121.952M 15.46% | -99.399M 18.49% | -126.48M -27.24% | -155.907M -23.27% | -192.525M -23.49% | -164.934M 14.33% | -107.304M 34.94% | -170.34M -58.75% | 135.15M 179.34% | 1.043B 671.74% | |
| EBIT YoY % growth | -120.33M -30.58% | -144.43M -20.03% | -122.271M 15.34% | -100.558M 17.76% | -122.022M -21.34% | -141.794M -16.20% | -94.845M 33.11% | 136.55M 243.97% | 359.92M 163.58% | 806.44M 124.06% | 478.18M -40.70% | 1.03B 115.40% | |
| Operating Margin | -590.43% | -62,795.65% | -38,939.81% | -17,784.77% | -47,851.80% | -46,338.07% | -121.22% | 39.36% | 54.28% | 67.60% | 41.01% | 56.69% | |
| EPS YoY % growth | N/A | -0.98 -14.66% | -0.29 70.41% | -0.84 -189.82% | -0.64 24.15% | -0.64 0.16% | -0.04 94.39% | 1.97 5,614.29% | 3.46 75.65% | 5.41 56.49% | 0.52 -90.39% | 3.70 611.76% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -23.25% | -0.15 10.00% | -0.16 56.79% | -0.16 -2.00% | -0.18 -20.69% |
| Revenue Q2Q % growth | 306K 1,600.00% | -100.00% | -100.00% | 382.5K 25.00% | |
| EBITDA Q2Q % growth | -25.806M 22.37% | -30.039M -35.91% | -30.855M -21.17% | -32.589M -45.79% | -33.15M -28.46% |
| EBIT Q2Q % growth | -26.688M 20.48% | -29.876M -34.67% | -32.374M -26.32% | -32.744M -44.87% | -35.177M -31.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.16 -164.00% | -0.16 | 0.00 | -0.12% |
| Q2 2024 Q2Q % growth | -0.36 -71.43% | -0.17 | -0.19 | -115.21% |
| Q1 2024 Q2Q % growth | -0.17 19.05% | -0.19 | 0.02 | 8.42% |
| Q4 2023 Q2Q % growth | -0.12 57.14% | -0.17 | 0.05 | 27.97% |
| Q3 2023 Q2Q % growth | 0.25 213.64% | -0.21 | 0.46 | 221.68% |
| Q2 2023 Q2Q % growth | -0.21 12.50% | -0.21 | 0.00 | 0.75% |
| Q1 2023 Q2Q % growth | -0.21 12.50% | -0.22 | 0.01 | 3.11% |
| Q4 2022 Q2Q % growth | -0.28 54.84% | -0.23 | -0.05 | -20.56% |
| Q3 2022 Q2Q % growth | -0.22 -4.76% | -0.24 | 0.02 | 7.35% |
| Q2 2022 Q2Q % growth | -0.24 35.14% | -0.24 | 0.00 | -1.97% |
| Q1 2022 Q2Q % growth | -0.24 -3,237.25% | -0.25 | 0.01 | 3.53% |
| Q4 2021 Q2Q % growth | -0.62 | -0.24 | -0.38 | -161.44% |
| Q3 2021 Q2Q % growth | -0.21 | -0.22 | 0.01 | 4.20% |
| Q2 2021 Q2Q % growth | -0.37 | -0.19 | -0.18 | -97.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 40K -54.02% | 40K | % | |
| Q2 2024 Q2Q % growth | 273K 58.72% | 273K | % | |
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 18K -55.00% | 191.352K | -173.352K | -90.59% |
| Q3 2023 Q2Q % growth | 87K 335.00% | 5.396K | 81.604K | 1,512.37% |
| Q2 2023 Q2Q % growth | 172K 1.18% | 6.457K | 165.543K | 2,563.94% |
| Q4 2022 Q2Q % growth | 40K -82.61% | 114.75K | -74.75K | -65.14% |
| Q3 2022 Q2Q % growth | 20K -92.59% | 20K | % | |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 19.88M | 20.284M | -404K | -1.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.57% | 0% | -0.18% |
| Revenue | 0% | -20% | 0% | -6.77% |